Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
VRDN holding history
Viridian Therapeutics, Inc. in every 13F filed by Merck & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings
- Shares (Q2 2026)
- 93,414
- Value
- $1.72M
- % of portfolio
- 0.3%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 93,414 | $1.72M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2026 | 93,414 | $1.83M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2025 | 93,414 | $2.91M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 93,414 | $2.02M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2025 | 93,414 | $1.31M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 93,414 | $1.26M | 0.8% | 00.0% | Unchanged | Holders |
| Q4 2024 | 93,414 | $1.79M | 0.7% | – | No prior filing | Holders |